JPS6349986B2 - - Google Patents
Info
- Publication number
- JPS6349986B2 JPS6349986B2 JP60219605A JP21960585A JPS6349986B2 JP S6349986 B2 JPS6349986 B2 JP S6349986B2 JP 60219605 A JP60219605 A JP 60219605A JP 21960585 A JP21960585 A JP 21960585A JP S6349986 B2 JPS6349986 B2 JP S6349986B2
- Authority
- JP
- Japan
- Prior art keywords
- barley
- water
- sugar
- weight
- mondo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 235000007340 Hordeum vulgare Nutrition 0.000 claims description 25
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 20
- 150000004676 glycans Chemical class 0.000 claims description 13
- 229920001282 polysaccharide Polymers 0.000 claims description 13
- 239000005017 polysaccharide Substances 0.000 claims description 13
- 235000013305 food Nutrition 0.000 claims description 10
- 150000001720 carbohydrates Chemical class 0.000 claims description 9
- 229920001542 oligosaccharide Polymers 0.000 claims description 6
- 150000002482 oligosaccharides Chemical class 0.000 claims description 6
- 240000005979 Hordeum vulgare Species 0.000 claims 1
- 241000209219 Hordeum Species 0.000 description 24
- 235000000346 sugar Nutrition 0.000 description 22
- 230000000694 effects Effects 0.000 description 17
- 230000004580 weight loss Effects 0.000 description 12
- 239000003814 drug Substances 0.000 description 9
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 description 8
- 229920002581 Glucomannan Polymers 0.000 description 8
- 239000000706 filtrate Substances 0.000 description 8
- 229940046240 glucomannan Drugs 0.000 description 8
- 241000196324 Embryophyta Species 0.000 description 7
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 6
- 208000008589 Obesity Diseases 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 6
- 210000000936 intestine Anatomy 0.000 description 6
- 235000020824 obesity Nutrition 0.000 description 6
- 210000002784 stomach Anatomy 0.000 description 6
- 206010011224 Cough Diseases 0.000 description 5
- 230000037396 body weight Effects 0.000 description 5
- 235000013402 health food Nutrition 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 230000037406 food intake Effects 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 206010058667 Oral toxicity Diseases 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 235000012054 meals Nutrition 0.000 description 3
- 231100000957 no side effect Toxicity 0.000 description 3
- 231100000418 oral toxicity Toxicity 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 229930182490 saponin Natural products 0.000 description 3
- 150000007949 saponins Chemical class 0.000 description 3
- 235000017709 saponins Nutrition 0.000 description 3
- 150000008163 sugars Chemical class 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 206010000060 Abdominal distension Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000000954 anitussive effect Effects 0.000 description 2
- 235000019658 bitter taste Nutrition 0.000 description 2
- 244000309464 bull Species 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 230000002354 daily effect Effects 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 208000004262 Food Hypersensitivity Diseases 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 241000234280 Liliaceae Species 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 102000014171 Milk Proteins Human genes 0.000 description 1
- 108010011756 Milk Proteins Proteins 0.000 description 1
- 201000002451 Overnutrition Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 244000141353 Prunus domestica Species 0.000 description 1
- 241000269821 Scombridae Species 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 239000003708 ampul Substances 0.000 description 1
- 239000003957 anion exchange resin Substances 0.000 description 1
- 239000003434 antitussive agent Substances 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 208000024330 bloating Diseases 0.000 description 1
- 239000004067 bulking agent Substances 0.000 description 1
- 239000003729 cation exchange resin Substances 0.000 description 1
- 208000029771 childhood onset asthma Diseases 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 229940124568 digestive agent Drugs 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000020932 food allergy Nutrition 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229930013032 isoflavonoid Natural products 0.000 description 1
- 150000003817 isoflavonoid derivatives Chemical class 0.000 description 1
- 235000012891 isoflavonoids Nutrition 0.000 description 1
- 235000020640 mackerel Nutrition 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 235000021239 milk protein Nutrition 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 235000020823 overnutrition Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000002250 progressing effect Effects 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 229930002534 steroid glycoside Natural products 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 235000021092 sugar substitutes Nutrition 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 230000009967 tasteless effect Effects 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 239000013598 vector Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
Description
〔イ〕 発明の目的
本発明は、麦門冬(バクモンドウ)の根、又は
根の膨大部から抽出した、糖類の新規な応用に関
する。
麦門冬とは、漢方名称であり、その植物学的名
称(基原)は、ユリ科のジヤノヒゲ、ヤブランな
ど次表(第1表)に示すごとくの根、又はそれら
の根の膨大部のことである。
[A] Object of the Invention The present invention relates to a novel application of saccharides extracted from the roots or the bulk of the roots of Barley mondo. Mugimondo is a Chinese medicine name, and its botanical name (base) refers to the roots of the Liliaceae family, such as Jyanohige and Yaburan, as shown in the following table (Table 1), or the ampulla of these roots. That's true.
【表】【table】
【表】
(産業上の利用分野)
本発明による麦門冬抽出糖類は、分子量が、
500〜10000の範囲にあり、経口投与されても、そ
のほとんどが胃や腸で分解されず、脂肪過多性の
肥満症(肥満体質者)に対する低カロリー食品又
は、減量剤として、健康食品などに用いることが
出来る。
本発明による麦門冬抽出糖類(以下、便宜上、
単に、麦門冬糖と略記する)の特徴は、上述した
肥満体質者のスリム効果が優れていると共に、鎮
咳作用を有し、あらゆる咳を止めるのに有効であ
る。
又、さらに、この他、腸内ビフイズス菌の増殖
剤、湿布剤、食品又は化粧品などの増粘剤、又は
保湿剤、賦形剤(増量剤)として、あるいは、医
薬、食品、化粧品類等の加工における、粉体、顆
粒、錠剤のコーテング剤としても利用出来る。
本発明による麦門冬糖は、経口毒性がなく、又
味は、ほとんど無味無臭であり、苦味を呈するこ
とがない、白色の粉末として得ることが出来る。
したがつて、乳幼児から大人まで、広く服用(経
口投与)が出来る。又、小児ぜんそくなどの虚弱
体質者、あるいは、食物アレルギー体質者の改善
にも効果的なものであり、健康食品のみならず、
医薬品の治療分野にも利用が可能である。
本発明による麦門冬糖は、上述したごとくの
500〜10000の分子量にある少糖類から多糖類から
なり、その総糖量は95〜98%以上であるが、従来
から麦門冬中の主役成分として知られている、サ
ボニン類やフラボノイド類などは、含まれていな
いことが特徴である。
(従来の技術)
麦門冬糖を、肥満症に利用したとの報告は、こ
れまで本発明以外には、まつたく見当らない。
一方、漢方では、麦門冬を咳止めや、痰切りに
用いられており、例えば、麦門冬湯は、こみ上げ
る様な、烈しいセキや、非常に粘つて出にくい痰
に用いられている。しかし、その有効成分につい
ては、これまで、麦門冬中のいかなる成分による
ものかは不明であつた。
麦門冬中に含まれる主な成分としては、ステロ
イド配糖体、ホモイソフラボノイド、オリゴサツ
カライドなどが含まれていることが報告されてい
る(後記刊行物)。しかし、本発明によるごとく
の麦門冬から得られた糖類が、咳や痰をともなう
症状に用いたとする文献は見当らない。
(刊行物の所在)
(1) 加藤ひさこら:薬誌
Vol.88、p.710(1968年)
(2) シヨオジJ.ら:ケミカル フアーマシユテイ
カル ブリチン(Shoji、J.、etal:Chem.
Pharm.Bull.)
Vol.20、p.1729(1972年)
Vol.21、p.308(1973年)
Vol.25、p.3049(1977年)
(3) タダ Aら:同上誌
(Tada、A.、etal:Chem.Pharm.Bull.)
Vol.28、p.1477(1980年)
p.2039( 〃 )
p.2487( 〃 )
(4) 友田正司ら:同上誌
Vol.16、p.113(1968年)
Vol.25、p.659(1973年)
(5) 友田正司ら:生薬誌
Vol.20、p.12(1966年)
最近の食生活の向上は、栄養過多などにともな
い、低カロリー食品、低糖類(生体内でエネルギ
ー化されない)食品が望まれている。なかでも、
高分子な多糖体繊維質を含む、野菜類の欠乏は、
これによつて、肥満体や小児アレルギー疾患を増
加し、あるいは糖尿病、動脈硬化症などの引金と
なつているとも推定されている。だからと言つ
て、植物のバルプ状繊維質は、これを多量に与え
れば、胃や腸に負担をかけ、その結果は、消化不
良をまねき、腹痛などを引き起こすことになる。
又、水に不溶性の高分子な多糖体繊維質ほど、こ
の傾向が高くなる。
したがつて、水溶性の小糖類や多糖類が望まれ
る。その代表的な例としては、グルコマンナンの
利用が知られている。しかし、肥満体質者の減量
効果となると、さほどの効果は得られず、これに
代替される糖類が望まれていた。
つまり、公知なグルコマンナンの利用は、これ
が胃や腸液などの水分の存在下で、何倍にも膨
潤、膨張させる性質を利用し、これによつて、満
腹感を与え、食事の摂取を抑制すること。つま
り、日常の食事を抑えることによつて、減量させ
ようとすることから、結果的には、一時的には減
量が可能であつても、さらに継続すれば、栄養失
調におちいり、他の副作用を引き起こしてしまう
ことが知られている。
(発明が解決しようとする問題点)
本発明者は、服用しても、腹部膨満感を与えな
いで、さらに栄養源とならないで、未消化の状態
で排便(体外に排泄)されやすい少糖、又は多糖
を求め、さまざまな植物を原料にして、これより
容易に目的を達成出来る、多糖の抽出を試みるこ
とから、研究を開始した。
従来の経口投与におけるスリム効果を有する成
分としては、前述したごとくのグルコマンナン
や、最近では、サポニン類が利用されているも、
これらの欠点は、グルコナンマンについては、先
に述べたごとくであり、サポニン類では、それを
達成するための量となると、相当量を必要とな
し、経口毒性、あるいは薬理的活性も強く、健康
食品としては、不向きな点が多い。つまり健康食
品としては、一にも二にも副作用がなく、安全性
が高く換言すれば、一回の食事量に相当する量
を、一度に食べても、何の副作用も示さないこと
が望ましいのである。この条件に対応するものと
なると、例えば、公知なグルコマンナンでは、そ
の膨脹性からも、又、水を大量に必要となす点で
も、不適当である。つまり、グルコマンナンは、
その一回に必要な摂取量となれば、約30〜50gで
あるが、これに要する水分は、少なくとも300〜
500mlを必要となし、これだけの水分を補給しな
い限り、正常な身体の保持が出来ないことであ
る。つまり、これ以上、一回に摂取すれば、それ
に相当する水を飲用する必要があり、結果とし
て、この摂取した水分を発散するための運動(ス
ポーツなど)が必要である。これがともなわいな
いで服用を続ければ、逆に下痢や便秘を誘発する
欠点が生じ、減量どころではなくなる。したがつ
て、グルコマンナンの減量を目的となして用いる
量は副作用の点を配慮して、1日量を3〜5g程
度を用い、これを毎日服用する形態の商品が主流
をなしているが、その効果は、充分発揮されない
でいた。
これに代替出来るものとしては、各種の果実中
のベクチンなどを主体とする利用が進んでいる。
その代表的なものとしては、プルーン中の多糖体
の利用であるが、これらの果実由来のものは、何
の副作用もなく、多量の水を必要とせず、減量効
果に優れていると言われている。
本発明者らは、この様な現状を把握し、健康食
品として用いられやすく、低カロリー食品とし
て、減量効果に優れた少糖及び多糖体の検索に当
つたわけである。そして、その条件をみたすもの
として、減量効果を副作用なく達成しえる、一つ
のポイントが、水を多量に必要とせず、服用が容
易であること。服部膨満感を与えないこと。水に
容易に溶解すること。さらに減量が副作用なく得
るための条件として、最も大きなポイントが、各
種の少糖、及び多糖中、分子量からすると、500
〜10000の範囲にあるものが最善であることがわ
かつた。すなわち、本発明にあつては、麦門冬糖
に限定し、その分子量が500〜10000の範囲を規定
するも、このポイントは、今後の低カロリー食品
類における糖類の応用に当つても有益であり、麦
門冬糖に限らず、他の植物由来の各種の少糖及び
多糖についても、この範囲内にあるものは、胃や
腸に負担を与えず、最善の減量効果を達成出来る
ための、一つの手段となりうることである。
〔ロ〕 発明の構成
本発明は、麦門冬から抽出した、糖類の分子量
を500〜10000の範囲となしたものを、低カロリー
食品に用いることからなる。以下に、具体的手段
について実施例等により示す。
(問題を解決するための手段)
実施例 1
麦門冬1Kgに対して、20倍量の水を加え、加熱
抽出後、濾過して、濾液を得る。この濾液にセラ
イト(ラジオライトNo.200、ラジオライトNo.600な
ど)を加え、濾過し、濾液を得て、次にアルミ
ナ、陽イオン交換樹脂、陰イオン交換樹脂、活性
炭を用いて順次通し、得られた液をそのままか、
又は4倍まで希釈(水を加え)した後、ペリコン
カセツトシステム(日本ミリポア・リミテツド
製)を用いて、分子量1万のペリコン膜を通し、
さらに、分子量1000のペリコン膜を通る溶出液を
除去し、得られた溶液(分子量1万から1000)を
乾燥して、白色粉末を得る。その総収量は700〜
900g程度得られる。このものは定量するとき、
総糖量が98%以上である。
実施例 2
麦門冬1Kgに、40倍量の水を加え、加熱抽出し
て、セライト濾過を行い、その濾液を得て、この
濾液に活性炭を加え、撹拌した後、濾過して得た
澄明な液体を乾燥し、乳白色状粉末を得る。又、
その収量は700〜900gが得られる。このものは定
量するとき、総糖量が95%以上である。
実施例 3
麦門冬1Kgに、20倍量の水を加え、加熱抽出し
てセライト濾過を行い、その濾液を得て、この濾
液を2分の1量〜5分の1量に濃縮し、濃縮液を
再度、濾過して澄明な粘稠液を得る。収量は800
g前後である。このものは、さらに乾燥粉末とな
すとき、その総糖量は95%以上である。
実施例 4
麦門冬1Kgに、20倍量の水を加え、加熱抽出し
て、セライト濾過を行い、次にこの濾液を活性炭
処理を行つた後、濃縮を行い、糖量が30〜70%と
なる、澄明粘稠な液を得る。その収量は800〜
2000gである。
上記した実施例で示す抽出法によれば、サポニ
ン類、イソフラボノイド類などの麦門冬中に含ま
れる薬効成分は除去されており、これにともなう
薬理的活性や経口毒性は示さない。又、得られた
抽出物は、目的とする麦門冬糖であるが、分子量
分布は、第1図に示すごとくとなり、500〜10000
の分子量範囲の糖類で構成されている。
又、各実施例では、スタート原料における麦門
冬に関し、とくに植物基原について限定しなかつ
たが、前表(第1表)に示すごとく、そのいずれ
の麦門冬を用いても抽出が可能である。すなわち
日局ではジヤノヒゲ根の膨大部を規定している。
しかし、わが国における漢方処方中に用いられて
いる麦門冬の多くは、容易に入手が可能である、
中国産のヤブラン、又はジヤノヒゲの根、又はそ
れらの根の膨大部がほとんどである。そこで、こ
の両植物の根及び根の膨大部を用いて、抽出を試
みたが、収量的には、両植物間には差異がなかつ
たことである。したがつて、麦門冬について、そ
の植物基原には、こだわる必要はとくにないと考
えられた。
尚、第1図における分子量分布について、その
測定条件については、次の通りである。
装置:高速液体クロマトグラフイー
日本分光製(TWINCLE)
検出器:RI(シマズ RID−2A)
カラム:Finepak SIL AF−102
温度:40℃
移動相:0.1M KH2PO、0.01M NaHPO4
0.2M Na2SO4水溶液
流速:1ml/min
一方、実施例で得られた麦門冬糖は、水に溶解
して、容易に溶けるも、ゲル形成能は、ほとんど
有していないことが特徴である。すなわち、従来
のグルコマンナンやペクチン類などの多糖体で
は、いずれもゲル形成能が高く、水を含むとカン
テン状に膨脹する特性を有して、これがために、
摂取後、他の食事を受け付けるスペースをなく
し、その結果、胃腸は満腹感を生じ、よつて減量
化を達成する手段となすことが出来る一つの条件
とされていたわけである。
〔ハ〕 発明の効果
本発明による麦門冬糖は、水に対する溶解性が
良好で、ゲル形成がないために、処方(配合)性
に優れ、飲料としての形態でも大量に添加して用
いることが出来る。又、摂取法(服用)後に、ゲ
ル形成能がなく、服部膨満感を与えることが少な
く、胃や腸で消化分解されにくい。したがつて、
低カロリー食品として最適である。
(作用又は効果の確認)
次表(第1表)は、まつたく減食をせず、肥満
体質のボランテイアをもとに、毎日朝昼晩の食前
に3〜10gを服用する方法を取り、2ケ月(60日
間)で、2Kgを服用(飲用)することを指示し、
1週間おきに体重の増減量を測定し、その成績結
果を示したものである。又、服用期間の2ケ月を
終了した後、さらに、投与中止後、30日を経過し
た時点で、体重を測定して調査した。
尚、第1表中、体重の測定は、6日目ごとに、
朝一番の排尿後に実施する方法で測定した。
一方、同様の投与(摂取)法により、ほぼ正常
の体重を有するボランテイアを選び、その投与期
間中の体重への増減に対して調べてみたが、その
結果は、肥満体質者には有効的な減量効果を示す
も、正常な体重を維持している者に対しては、と
くに体重を低下させた例は認められなかつた。し
たがつて、麦門冬糖は、選択的に、肥満体質者に
対してのみ、有効的に働く様にうかがえられた。
又、両試験中、共に副作用的な症状の訴えはなか
つた。又、下痢や便秘を訴えたものもなかつた
が、快便、快腸であるとするものが多く、整腸剤
又は消化剤が入つているのかと、疑われる程、逆
に投与期間中は、食欲が増進したとの報告が寄せ
られた。[Table] (Industrial Application Field) The barley mondo extracted saccharide according to the present invention has a molecular weight of
It is in the range of 500 to 10,000, and even if administered orally, most of it is not broken down in the stomach or intestines, so it is used as a low-calorie food for obese people with excessive fat content (obese people), or as a health food as a weight loss agent. It can be used. Bakumonfuyu extracted saccharide according to the present invention (hereinafter, for convenience,
(simply abbreviated as barley mondo sugar) is characterized by its excellent slimming effect on obese people as described above, as well as its antitussive effect and is effective in stopping all kinds of coughs. In addition, it can also be used as a growth agent for intestinal bifidobacteria, as a poultice, as a thickener for foods or cosmetics, or as a moisturizing agent, excipient (bulking agent), or as a filler for pharmaceuticals, foods, cosmetics, etc. It can also be used as a coating agent for powder, granules, and tablets during processing. The barley hilt sugar according to the present invention has no oral toxicity, is almost tasteless and odorless, and can be obtained as a white powder without bitterness.
Therefore, it can be administered (orally) to a wide range of people from infants to adults. It is also effective for improving people with weak constitutions such as those with childhood asthma, or those with food allergies, and is not only a health food.
It can also be used in the field of pharmaceutical therapy. The barley mondo sugar according to the present invention is as described above.
It consists of oligosaccharides to polysaccharides with a molecular weight of 500 to 10,000, and the total sugar content is 95 to 98% or more, but it contains savonins and flavonoids, which have traditionally been known as the main components of barley. is characterized in that it is not included. (Prior Art) To date, there have been no reports other than the present invention of the use of barley portal sugar for obesity. On the other hand, in Chinese medicine, Bakumondoto is used to suppress coughs and remove phlegm. For example, Bakumondoto is used to treat intense coughs that seem to be rising up, and phlegm that is very sticky and difficult to get out. However, until now, it was unknown what kind of active ingredient it is. It has been reported that the main components contained in Bakumonto include steroid glycosides, homoisoflavonoids, and oligosaccharides (see later publications). However, no literature has been found that states that saccharides obtained from barley mondo according to the present invention are used for symptoms associated with coughs and sputum. (Publication location) (1) Hisakola Kato et al.: Pharmaceutical Journal Vol. 88, p. 710 (1968) (2) Shoji J. et al.: Chemical Pharmaceutical Bulletin (Shoji, J., etal: Chem.
Pharm.Bull.) Vol.20, p.1729 (1972) Vol.21, p.308 (1973) Vol.25, p.3049 (1977) (3) Tada A et al. A., etal: Chem.Pharm.Bull.) Vol. 28, p. 1477 (1980) p. 2039 ( 〃 ) p. 2487 ( 〃 ) (4) Masashi Tomoda et al.: Vol. 16, p. 113 (1968) Vol. 25, p. 659 (1973) (5) Shoji Tomoda et al.: Journal of Herbal Medicine Vol. 20, p. 12 (1966) Recent improvements in dietary habits have resulted in overnutrition. Low calorie foods and low sugar foods (which cannot be converted into energy within the body) are desired. Among them,
Deficiency of vegetables containing high-molecular polysaccharide fiber is caused by
It is estimated that this is causing an increase in obesity and allergic diseases in children, as well as triggering diabetes and arteriosclerosis. However, if large amounts of plant fiber are given, it will put a strain on the stomach and intestines, resulting in indigestion and abdominal pain.
Furthermore, the higher the water-insoluble polymeric polysaccharide fiber, the higher this tendency. Therefore, water-soluble small saccharides and polysaccharides are desired. As a typical example, the use of glucomannan is known. However, when it comes to reducing weight in obese people, it is not very effective, and there has been a desire for a sugar substitute. In other words, the known use of glucomannan takes advantage of its property of swelling and expanding many times in the presence of water such as stomach and intestinal fluid, thereby giving a feeling of fullness and suppressing food intake. to do. In other words, people try to lose weight by restricting their daily diet, and even if weight loss is possible temporarily, if it continues, malnutrition and other side effects may occur. It is known to cause (Problems to be Solved by the Invention) The present inventor has discovered that the present invention does not cause abdominal distension even when taken, does not serve as a nutritional source, and is easily excreted in the defecation (excreted from the body) in an undigested state. In search of polysaccharides, we began our research by attempting to extract polysaccharides that could more easily achieve our goals using various plants as raw materials. Conventional ingredients that have a slimming effect when administered orally include glucomannan, as mentioned above, and recently, saponins.
These drawbacks are as mentioned above for gluconanman, and for saponins, a considerable amount is not required to achieve this, oral toxicity or pharmacological activity is strong, and it is not suitable for health foods. As such, there are many disadvantages. In other words, as a health food, it is desirable that it has no side effects and is highly safe.In other words, it is desirable that it not show any side effects even if you eat the amount equivalent to one meal at a time. It is. When it comes to meeting this condition, for example, known glucomannan is unsuitable due to its expansive nature and the need for a large amount of water. In other words, glucomannan is
The amount of water required at one time is approximately 30-50g, but the amount of water required for this is at least 300-50g.
500ml is required, and unless you replenish this amount of water, your body will not be able to maintain its normal state. In other words, if you ingest more water at once, you will need to drink the equivalent amount of water, and as a result, you will need to exercise (such as sports) to burn off the water you have ingested. If you continue to take the drug without this, you will have the disadvantage of inducing diarrhea and constipation, which will make it impossible to lose weight. Therefore, the amount of glucomannan used for the purpose of weight loss is around 3 to 5 g per day, taking into account side effects, and products that are taken daily are the mainstream. However, its effects were not fully demonstrated. As an alternative to this, the use of mainly vectors found in various fruits is progressing.
A typical example of this is the use of polysaccharides in prunes; products derived from these fruits are said to have no side effects, do not require large amounts of water, and are excellent in weight loss effects. ing. The present inventors understood the current situation and searched for oligosaccharides and polysaccharides that can be easily used as health foods, are low-calorie foods, and have excellent weight loss effects. One of the key points that satisfies this condition and allows weight loss to be achieved without side effects is that it does not require large amounts of water and is easy to take. Hattori:Do not give a feeling of bloating. Easily soluble in water. Furthermore, as a condition for weight loss without side effects, the most important point is that the molecular weight of various oligosaccharides and polysaccharides is 500%.
I've found that something in the ~10000 range is best. That is, in the present invention, the molecular weight is limited to barley portal sugar and is defined in the range of 500 to 10,000, but this point will be useful in the future application of sugars in low-calorie foods. Not only barley sugar, but also various oligosaccharides and polysaccharides derived from other plants, within this range are recommended to achieve the best weight loss effect without putting a burden on the stomach or intestines. , this could be one means. [B] Structure of the Invention The present invention consists of using saccharides extracted from barley mondo with a molecular weight in the range of 500 to 10,000 for low-calorie foods. Specific means will be shown below using Examples. (Means for solving the problem) Example 1 20 times the amount of water is added to 1 kg of Mugimonfu, heated and extracted, and then filtered to obtain a filtrate. Celite (Radiolite No. 200, Radiolite No. 600, etc.) is added to this filtrate and filtered to obtain a filtrate, which is then sequentially passed through alumina, cation exchange resin, anion exchange resin, and activated carbon. Leave the obtained liquid as it is, or
Or, after diluting up to 4 times (adding water), pass it through a Pellicon membrane with a molecular weight of 10,000 using a Pellicon cassette system (manufactured by Nippon Millipore Limited).
Furthermore, the eluate passing through the Pellicon membrane with a molecular weight of 1000 is removed, and the resulting solution (molecular weight 10,000 to 1000) is dried to obtain a white powder. Its total yield is 700 ~
You can get about 900g. When quantifying this,
Total sugar content is 98% or more. Example 2 40 times the amount of water was added to 1 kg of Mugimonfu, heated and extracted, and filtered through Celite to obtain the filtrate. Activated carbon was added to the filtrate, stirred, and filtered to obtain a clear solution. Dry the liquid to obtain a milky white powder. or,
The yield is 700-900g. When quantified, this product has a total sugar content of 95% or more. Example 3 Add 20 times the amount of water to 1 kg of Mugimonfu, heat extraction and celite filtration to obtain the filtrate, concentrate this filtrate to 1/2 to 1/5 volume, The concentrate is filtered again to obtain a clear viscous liquid. Yield is 800
It is around g. When this product is further made into a dry powder, its total sugar content is 95% or more. Example 4 Add 20 times the amount of water to 1 kg of barley Mondou, heat and extract, filter through Celite, then treat the filtrate with activated carbon, and concentrate to reduce the sugar content to 30-70%. Obtain a clear and viscous liquid. Its yield is 800 ~
It is 2000g. According to the extraction method shown in the above-mentioned Examples, the medicinal components contained in Mumondo, such as saponins and isoflavonoids, are removed, and the resulting pharmacological activity and oral toxicity are not exhibited. In addition, the obtained extract is the target barley portal sugar, but the molecular weight distribution is as shown in Figure 1, ranging from 500 to 10,000.
It is composed of sugars with a molecular weight range of . In addition, in each Example, regarding the starting material, barley mondo, there was no particular limitation on the plant base, but as shown in the previous table (Table 1), extraction can be performed using any of the barley mondo. It is. In other words, the Japanese Bureau stipulates the bulk of the root of the jianohige.
However, most of the barley monfu used in traditional Chinese medicine prescriptions in Japan are easily available.
Most of them are the roots of Chinese herbaceous or jianohige, or the bulk of these roots. Therefore, extraction was attempted using the roots and bulk of the roots of both plants, but there was no difference between the two plants in terms of yield. Therefore, it was thought that there was no need to be particular about the plant origins of Mugimonfuyu. The measurement conditions for the molecular weight distribution in FIG. 1 are as follows. Equipment: High Performance Liquid Chromatography (TWINCLE) Detector: RI (Shimazu RID-2A) Column: Finepak SIL AF-102 Temperature: 40℃ Mobile phase: 0.1M KH 2 PO, 0.01M NaHPO 4 0.2M Na 2 SO 4 aqueous solution flow rate: 1 ml/min On the other hand, the barley montage obtained in the examples is characterized by having almost no gel-forming ability, although it dissolves easily in water. In other words, conventional polysaccharides such as glucomannan and pectins all have a high gel-forming ability and have the property of expanding like an agar when they contain water.
After ingestion, there is no space left for other meals, resulting in a feeling of fullness in the stomach and intestines, which is one of the conditions that can be used as a means to achieve weight loss. [C] Effects of the Invention The barley hilt sugar according to the present invention has good solubility in water and does not form a gel, so it has excellent formulation (compounding) properties and can be used in the form of a drink by adding it in large quantities. I can do it. Furthermore, after ingestion (dose), it has no gel-forming ability, rarely gives a feeling of fullness, and is difficult to be digested and broken down in the stomach and intestines. Therefore,
It is ideal as a low calorie food. (Confirmation of action or effect) The following table (Table 1) shows a method of taking 3 to 10 g before meals in the morning, noon, and evening every day, based on obese volunteers who did not immediately reduce their diet. Instructed to take (drink) 2 kg in 60 days.
Weight gain/loss was measured every other week, and the results are shown. Furthermore, after the completion of the 2-month dosing period and 30 days after discontinuation of administration, the weight was measured and investigated. In addition, in Table 1, body weight was measured every 6th day.
It was measured after the first urination in the morning. On the other hand, using the same administration (ingestion) method, we selected volunteers with approximately normal body weight and examined the changes in body weight during the administration period. Although the drug showed a weight loss effect, no particular reduction in body weight was observed in those who maintained a normal body weight. Therefore, barley mondo sugar appears to be selectively effective only in obese individuals.
In addition, there were no complaints of side effects during both tests. In addition, although none of the patients complained of diarrhea or constipation, many of them reported having easy stools and intestines, which led to the suspicion that the drug contained an intestinal regulating agent or digestive agent. There have been reports of an increase in
【表】
第1表に示すごとくの成績結果からしてみる
と、従来はグルコマンナンの、高分子な多糖体が
利用されていたのに対し、ゲル形成能の低い500
〜10000の分子量にある麦門冬糖は、その利用に
当つて、服用も容易であり、又、他の処方中にも
配合しやすい点で、望ましいものであることがわ
かつた。尚、第1表中、肥満体の判定に当つて
は、身長と体重との関係から一つの基準が示され
ており、例えば、社団法人日本栄養士会発行の
「健康増進のしおりNo.21」中のグラフ(第2図)
をもとに、ボランテイアを選択して、試験に当つ
た。
一方、麦門冬糖は、これを服用1〜2g1回で
用いると咳が止まる。通常、クスリとして投与さ
れる鎮咳剤は、薬理的活性も強く、長期連用すれ
ば、その副作用として習慣性をもつたもの、胃腸
障害を有するもの、あるいは苦味を有したものな
どが多いが、そのような副作用は、まつたく認め
られないのが特徴である。又、虚弱体質者、アレ
ルギー症を有し、牛乳蛋白、卵白、サバなどのサ
シミによつて発疹し、あるいは、ぜんそくなどを
有した症状の人々に対しては、その体質改善剤と
しても有効である。第2表は、麦門冬糖を用いて
2〜3の症状に対して、その投与経過を示したも
のである。
これまで、麦門冬から抽出された糖類につい
て、この様な作用(効果)があるとの報告は知ら
れていないが、本発明による麦門冬糖は、これら
の治療剤、又は体質改善剤としても有益である。
しかし、その作用機序については不明である。[Table] Judging from the performance results shown in Table 1, conventionally a high-molecular polysaccharide of glucomannan was used, whereas
It has been found that barley portal sugar, which has a molecular weight of ~10,000, is desirable in that it is easy to take and can be easily incorporated into other formulations. In addition, in Table 1, when determining obesity, one standard is shown based on the relationship between height and weight, for example, "Health Promotion Booklet No. 21" published by the Japan Dietetic Association. Graph inside (Figure 2)
Based on this, volunteers were selected to take the test. On the other hand, using 1 to 2 g of barley mondo sugar at a time will stop coughing. Antitussives, which are usually administered as medicines, have strong pharmacological activity, and when used for a long period of time, many of the side effects are addictive, cause gastrointestinal disorders, or have a bitter taste. It is characteristic that no side effects are observed. It is also effective as a physical condition improvement agent for people with weak constitutions, allergies, rashes caused by milk protein, egg white, mackerel, etc., or people with symptoms such as asthma. be. Table 2 shows the course of administration of barley mondo sugar for a few symptoms. Until now, there have been no reports that saccharides extracted from barley mondo have such actions (effects), but barley mondo sugar according to the present invention can be used as a therapeutic agent for these or as a constitution improving agent. It is also beneficial.
However, its mechanism of action is unknown.
第1図は、G.P.C.(gel permiation
chromatography)の理論をもとに、高速液体ク
ロマトグラフイー(H.P.L.C.)を行い、麦門冬か
ら抽出した糖類の、その分子量分布を測定した結
果を示す。第2図は、肥満の判定に当つて基準と
して用いた、身長別体重による肥満の判定表(グ
ラフ)。イの巾にあるときは、ほぼ正常な体重を
示す。ロの巾にあるときは、要注意の体重を示
す。ハ以上にあるときは、肥満を現わし、減量が
必要である。
Figure 1 shows GPC (gel permation)
We performed high-performance liquid chromatography (HPLC) based on the theory of chromatography, and show the results of measuring the molecular weight distribution of sugars extracted from Mugimondo. Figure 2 is a chart (graph) for determining obesity based on weight by height, which was used as a standard for determining obesity. When it is within the width of A, it indicates an almost normal weight. When it is within the width of the circle, it indicates a weight that requires attention. When it is above Ha, it indicates obesity and weight loss is necessary.
Claims (1)
き定量するとき、95%以上にあり、かつ、抽出し
た糖類を構成する分子量が、500〜10000の範囲内
にある、少糖類又は多糖類を含有することを特徴
とする、低カロリー食品。1. Oligosaccharides or polysaccharides in which the total amount of saccharides extracted from barley monfu is 95% or more when quantified excluding water, and the molecular weight of the extracted saccharides is within the range of 500 to 10,000. A low-calorie food characterized by containing.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP60219605A JPS6279754A (en) | 1985-10-01 | 1985-10-01 | Low-caloric food containing saccharide extracted from ophiopogonis tuber |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP60219605A JPS6279754A (en) | 1985-10-01 | 1985-10-01 | Low-caloric food containing saccharide extracted from ophiopogonis tuber |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS6279754A JPS6279754A (en) | 1987-04-13 |
JPS6349986B2 true JPS6349986B2 (en) | 1988-10-06 |
Family
ID=16738148
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP60219605A Granted JPS6279754A (en) | 1985-10-01 | 1985-10-01 | Low-caloric food containing saccharide extracted from ophiopogonis tuber |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS6279754A (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS63309183A (en) * | 1987-06-12 | 1988-12-16 | Ichimaru Pharcos Co Ltd | Bifidus-proliferation agent containing sugars extracted from 'bakumonto' |
JP2006003649A (en) | 2004-06-17 | 2006-01-05 | Brother Ind Ltd | Image forming apparatus |
US9376824B2 (en) | 2006-12-12 | 2016-06-28 | United States Gypsum Company | Nonwoven joint tape having low moisture expansion properties and method for using same |
CN102757508B (en) * | 2011-04-25 | 2015-11-25 | 上海张江中药现代制剂技术工程研究中心 | A kind of Radix Ophiopogonis polysaccharide extract has the application in the foodstuff additive of weight losing function, healthcare products or medicine in preparation |
-
1985
- 1985-10-01 JP JP60219605A patent/JPS6279754A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS6279754A (en) | 1987-04-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9155773B2 (en) | Antiobesity composition | |
JP6271571B2 (en) | Composition for maintaining intestinal microbiota equilibrium, process for producing the composition, and use of the composition | |
ES2356536B1 (en) | A composition used as a prebiotic that contains a pomegranate extract and a food that includes said composition. | |
AU2003227438B2 (en) | Compositions for preventing or treating pollenosis, allergic nephritis, atopic dermatitits, asthma or urticaria | |
CN102198262B (en) | Chinese medicine preparation for treating infant rotavirus enteritis and preparation method thereof | |
CN102613566B (en) | Health care product for relaxing bowel and preparation method of heath care product | |
Das et al. | Okra and its various applications in drug delivery, food technology, health care and pharmacological aspects-a review | |
KR102132066B1 (en) | Antioxidant and anti-Obesity composition comprising Psyllium Husk and Kaempferia parviflora, formulatiom using the composition and preparing method thereof | |
WO2013013496A1 (en) | Drink composition for clearing inner heat and preparation method thereof | |
CN103168883A (en) | Pathogenic microorganism preventing antiviral tea beverage granules capable of boosting immunity and preparation method thereof | |
AU2016253140B2 (en) | Plant extracts for the treatment of excess weight and obesity | |
Hoffmann | Healthy digestion: A natural approach to relieving indigestion, gas, heartburn, constipation, colitis, and more | |
JPH11130686A (en) | Prevention and curing of obesity, and anti-obesity agent | |
JP4516958B2 (en) | Anti-diabetic composition | |
US20050276869A1 (en) | Appetite-suppressing, lipase-inhibiting herbal composition | |
JPS6349986B2 (en) | ||
KR101910013B1 (en) | A composition for improving, preventing and treating of pain comprising herb extract | |
CN113769029B (en) | Medicinal and edible herbal composition for improving intestinal absorption and immune function | |
CA2408023C (en) | Glucosamine as a food and beverage additive | |
JP4589900B2 (en) | Mozuku-derived fucoidan-containing agent | |
Mahboubi | Prunus domestica as effective and acceptable treatment for stool softening and relief of constipation symptoms. | |
JP2009007328A (en) | Antiallergic composition | |
GB2446373A (en) | Natural laxative composition for treating and preventing constipation with colon cleansing action | |
CN110801474A (en) | Composition for preventing and treating constipation and application thereof | |
Fossum | Assessment report on Sambucus nigra L., fructus |